Izba (travoprost)

pCPA File Number: 21026

Negotiation Status:

Concluded with an LOI

Indication(s):

Open-angle Glaucoma

Sponsor/Manufacturer:

Novartis Pharmaceuticals Canada Inc.

CDA-AMC Project Number:

SR0516-000

pCPA Engagement Letter Issued:

2018-04-12

Negotiation Process Concluded:

2018-12-06